Search Results

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors by Menzel, Michael (Author) , Kirchner, Martina (Author) , Kluck, Klaus (Author) , Ball, Markus (Author) , Beck, Susanne (Author) , Allgäuer, Michael (Author) , Assmann, Christin (Author) , Schnorbach, Johannes (Author) , Volckmar, Anna-Lena (Author) , Tay, Timothy Kwang Yong (Author) , Goldschmid, Hannah (Author) , Tan, Daniel SW (Author) , Thomas, Michael (Author) , Kazdal, Daniel (Author) , Budczies, Jan (Author) , Stenzinger, Albrecht (Author) , Christopoulos, Petros (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial by Fassunke, Jana (Author) , Penzel, Roland (Author) , Volckmar, Anna-Lena (Author) , Stenzinger, Albrecht (Author) , Endris, Volker (Author) , Schirmacher, Peter (Author) ,


    Get full text
    Article (Journal) Online Resource